Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Oncology Drugs Market, by Indication
1.4.2 North America Oncology Drugs Market, by Drug Class Type
1.4.3 North America Oncology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Oncology Drugs Market by Indication
5.1 North America Breast Cancer Market by Country
5.2 North America Prostate Cancer Market by Country
5.3 North America Lung Cancer Market by Country
5.4 North America Stomach Cancer Market by Country
5.5 North America Colorectal Cancer Market by Country
5.6 North America Liver Cancer Market by Country
5.7 North America Esophagus Cancer Market by Country
5.8 North America Cervical Cancer Market by Country
5.9 North America Kidney Cancer Market by Country
5.10. North America Bladder Cancer Market by Country
5.11 North America Other Cancer Market by Country
Chapter 6. North America Oncology Drugs Market by Drug Class Type
6.1 North America Targeted Therapy Market by Country
6.2 North America Immunotherapy (Biologic Therapy) Market by Country
6.3 North America Chemotherapy Market by Country
6.4 North America Hormonal Therapy Market by Country
Chapter 7. North America Oncology Drugs Market by Country
7.1 US Oncology Drugs Market
7.1.1 US Oncology Drugs Market by Indication
7.1.2 US Oncology Drugs Market by Drug Class Type
7.2 Canada Oncology Drugs Market
7.2.1 Canada Oncology Drugs Market by Indication
7.2.2 Canada Oncology Drugs Market by Drug Class Type
7.3 Mexico Oncology Drugs Market
7.3.1 Mexico Oncology Drugs Market by Indication
7.3.2 Mexico Oncology Drugs Market by Drug Class Type
7.4 Rest of North America Oncology Drugs Market
7.4.1 Rest of North America Oncology Drugs Market by Indication
7.4.2 Rest of North America Oncology Drugs Market by Drug Class Type
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Amgen, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Bristol Myers Squibb Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional & Segmental Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 North America Oncology Drugs Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Oncology Drugs Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2019, Mar – 2023, Nov) Leading Players
FIG 7 Porter’s Five Forces Analysis - Oncology Drugs Market
FIG 8 North America Oncology Drugs Market share by Indication, 2022
FIG 9 North America Oncology Drugs Market share by Indication, 2030
FIG 10 North America Oncology Drugs Market by Indication, 2019 - 2030, USD Million
FIG 11 North America Oncology Drugs Market share by Drug Class Type, 2022
FIG 12 North America Oncology Drugs Market share by Drug Class Type, 2030
FIG 13 North America Oncology Drugs Market by Drug Class Type, 2019 - 2030, USD Million
FIG 14 North America Oncology Drugs Market share by Country, 2022
FIG 15 North America Oncology Drugs Market share by Country, 2030
FIG 16 North America Oncology Drugs Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: AbbVie, Inc.
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 Swot Analysis: Amgen, Inc.
FIG 20 Recent strategies and developments: Astellas Pharma, Inc.
FIG 21 SWOT Analysis: Astellas Pharma, Inc.
FIG 22 Recent strategies and developments: AstraZeneca PLC
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 Recent strategies and developments: Bristol Myers Squibb Company
FIG 25 SWOT Analysis: Bristol Myers Squibb Company
FIG 26 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 27 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 28 Recent strategies and developments: Johnson & Johnson
FIG 29 Swot Analysis: Johnson & Johnson
FIG 30 SWOT Analysis: Novartis AG
FIG 31 Recent strategies and developments: Merck & Co., Inc.
FIG 32 SWOT Analysis: Merck & Co., Inc.
FIG 33 SWOT Analysis: Pfizer, Inc.

List of Tables

TABLE 1 North America Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 2 North America Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Oncology Drugs Market
TABLE 4 Product Launches And Product Expansions– Oncology Drugs Market
TABLE 5 Acquisition and Mergers– Oncology Drugs Market
TABLE 6 North America Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 7 North America Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 8 North America Breast Cancer Market by Country, 2019 - 2022, USD Million
TABLE 9 North America Breast Cancer Market by Country, 2023 - 2030, USD Million
TABLE 10 North America Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 12 North America Lung Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Lung Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 14 North America Stomach Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 15 North America Stomach Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 16 North America Colorectal Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 17 North America Colorectal Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 18 North America Liver Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 19 North America Liver Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 20 North America Esophagus Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Esophagus Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 22 North America Cervical Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Cervical Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 24 North America Kidney Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Kidney Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 26 North America Bladder Cancer?Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Bladder Cancer?Market by Country, 2023 - 2030, USD Million
TABLE 28 North America Other Cancer Market by Country, 2019 - 2022, USD Million
TABLE 29 North America Other Cancer Market by Country, 2023 - 2030, USD Million
TABLE 30 North America Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 31 North America Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 32 North America Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 33 North America Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 34 North America Immunotherapy (Biologic Therapy) Market by Country, 2019 - 2022, USD Million
TABLE 35 North America Immunotherapy (Biologic Therapy) Market by Country, 2023 - 2030, USD Million
TABLE 36 North America Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 37 North America Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 38 North America Hormonal Therapy Market by Country, 2019 - 2022, USD Million
TABLE 39 North America Hormonal Therapy Market by Country, 2023 - 2030, USD Million
TABLE 40 North America Oncology Drugs Market by Country, 2019 - 2022, USD Million
TABLE 41 North America Oncology Drugs Market by Country, 2023 - 2030, USD Million
TABLE 42 US Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 43 US Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 44 US Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 45 US Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 46 US Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 47 US Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 48 Canada Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 49 Canada Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 50 Canada Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 51 Canada Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 52 Canada Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 53 Canada Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 54 Mexico Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 55 Mexico Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 56 Mexico Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 57 Mexico Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 58 Mexico Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 59 Mexico Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 60 Rest of North America Oncology Drugs Market, 2019 - 2022, USD Million
TABLE 61 Rest of North America Oncology Drugs Market, 2023 - 2030, USD Million
TABLE 62 Rest of North America Oncology Drugs Market by Indication, 2019 - 2022, USD Million
TABLE 63 Rest of North America Oncology Drugs Market by Indication, 2023 - 2030, USD Million
TABLE 64 Rest of North America Oncology Drugs Market by Drug Class Type, 2019 - 2022, USD Million
TABLE 65 Rest of North America Oncology Drugs Market by Drug Class Type, 2023 - 2030, USD Million
TABLE 66 Key information – AbbVie, Inc.
TABLE 67 Key Information – Amgen, Inc.
TABLE 68 key information – Astellas Pharma, Inc.
TABLE 69 KEY INFORMATION – AstraZeneca PLC
TABLE 70 Key Information – Bristol Myers Squibb Company
TABLE 71 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Johnson & Johnson
TABLE 73 Key Information – Novartis AG
TABLE 74 Key Information - Merck & Co., Inc.
TABLE 75 Key Information – Pfizer, Inc.